ATE396204T1 - Peptide als antiangiogene arzneimittel - Google Patents

Peptide als antiangiogene arzneimittel

Info

Publication number
ATE396204T1
ATE396204T1 AT99927091T AT99927091T ATE396204T1 AT E396204 T1 ATE396204 T1 AT E396204T1 AT 99927091 T AT99927091 T AT 99927091T AT 99927091 T AT99927091 T AT 99927091T AT E396204 T1 ATE396204 T1 AT E396204T1
Authority
AT
Austria
Prior art keywords
peptides
antiangiogenic drugs
antiangiogenic
drugs
Prior art date
Application number
AT99927091T
Other languages
English (en)
Inventor
Jack Henkin
Fortuna Haviv
Michael Bradley
Douglas Kalvin
Andrew Schneider
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE396204T1 publication Critical patent/ATE396204T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
AT99927091T 1998-05-22 1999-05-21 Peptide als antiangiogene arzneimittel ATE396204T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8374598A 1998-05-22 1998-05-22
US25057499A 1999-02-16 1999-02-16
US27746699A 1999-03-26 1999-03-26

Publications (1)

Publication Number Publication Date
ATE396204T1 true ATE396204T1 (de) 2008-06-15

Family

ID=27374598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99927091T ATE396204T1 (de) 1998-05-22 1999-05-21 Peptide als antiangiogene arzneimittel

Country Status (26)

Country Link
EP (1) EP1078002B1 (de)
JP (3) JP3753612B2 (de)
KR (1) KR100447696B1 (de)
CN (1) CN1311796A (de)
AR (1) AR018371A1 (de)
AT (1) ATE396204T1 (de)
AU (1) AU764277B2 (de)
BG (1) BG65065B1 (de)
BR (1) BR9910639A (de)
CA (1) CA2329250C (de)
CO (1) CO5080726A1 (de)
CY (1) CY1109118T1 (de)
CZ (1) CZ299639B6 (de)
DE (1) DE69938782D1 (de)
ES (1) ES2307337T3 (de)
HK (1) HK1037376A1 (de)
HU (1) HUP0102579A3 (de)
NO (1) NO326871B1 (de)
NZ (1) NZ507912A (de)
PL (1) PL200471B1 (de)
PT (1) PT1078002E (de)
SI (1) SI1078002T1 (de)
SK (1) SK286554B6 (de)
TR (1) TR200003442T2 (de)
TW (1) TWI247748B (de)
WO (1) WO1999061476A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774211B1 (en) 1998-05-22 2004-08-10 Abbott Laboratories Peptide antiangiogenic drugs
US6753310B1 (en) 1998-10-16 2004-06-22 Otsuka Pharmaceutical Co., Ltd. Neovascular-specific peptides
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
HU228582B1 (en) 1998-10-23 2013-04-29 Kirin Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US20020183242A1 (en) * 2001-04-11 2002-12-05 Jack Henkin Peptide antiangiogenic drugs
US20030050246A1 (en) * 2001-07-26 2003-03-13 Fortuna Haviv Peptides having antiangiogenic activity
UY27523A1 (es) * 2001-10-31 2003-05-30 Abbott Lab Tetra-, penta-, hexa-y heptapéptidos con actividad antiangiogénica
US7122625B2 (en) 2001-10-31 2006-10-17 Abbott Laboratories Hexa-, hepta-, and octapeptides having antiangiogenic activity
US20030125259A1 (en) 2001-10-31 2003-07-03 Fortuna Haviv Octa- and nonapeptides having antiangiogenic activity
US20030119746A1 (en) * 2001-10-31 2003-06-26 Fortuna Haviv Hepta-and octapeptides having antiangiogenic activity
NZ532367A (en) * 2001-10-31 2006-01-27 Abbott Lab HEPTA-, OCTA- and nonapeptides having antiangiogenic activity
US7037897B2 (en) 2001-10-31 2006-05-02 Abbott Laboratories TRI-, TETRA-, and penta-peptides having antiangiogenic activity
US20030105025A1 (en) * 2001-10-31 2003-06-05 Fortuna Haviv Tri-and tetrapeptides having antiangiogenic activity
US7067490B2 (en) 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US20030125260A1 (en) * 2001-10-31 2003-07-03 Fortuna Haviv Tetra-and pentapeptides having antiangiogenic activity
US7169888B2 (en) 2001-10-31 2007-01-30 Abbott Laboratories Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
US7001984B2 (en) 2001-10-31 2006-02-21 Abbott Laboratories Di-, tri-, and tetra-peptides having antiangiogenic activity
KR20040106291A (ko) 2002-03-22 2004-12-17 지피씨 바이오테크 아게 면역억제 화합물, 이의 제조 방법 및 용도
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
US7432245B2 (en) 2002-06-07 2008-10-07 Abbott Laboratories Inc. Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
EP1853294A4 (de) 2005-03-03 2010-01-27 Covx Technologies Ireland Ltd Antiangiogene verbindungen
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
JP2007255910A (ja) * 2006-03-20 2007-10-04 Hokkaido Univ Ｎｍｒシグナルの帰属方法
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2008003013A2 (en) * 2006-06-29 2008-01-03 Abbott Laboratories Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic
CN104004057B (zh) * 2013-02-25 2016-08-24 上海市第一人民医院 一类抑制新生血管的小肽及其应用
CN107778355B (zh) * 2016-08-25 2021-04-20 成都圣诺生物制药有限公司 一种合成西曲瑞克的方法
TW202328059A (zh) * 2021-09-01 2023-07-16 日商積水醫療股份有限公司 精胺酸衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
WO1993016716A1 (en) * 1992-02-24 1993-09-02 Northwestern University Method and composition for inhibiting angiogenesis
HU224827B1 (hu) * 1996-05-03 2006-02-28 Abbott Lab Új antiangiogén peptidek, azokat kódoló polinukleotidok, és eljárások angiogenezis gátlására
DK0918795T3 (da) * 1997-03-17 2005-03-14 Abbott Lab Antiangiogene lægemidler til behandling af cancer, arthritis og retinopati

Also Published As

Publication number Publication date
HUP0102579A3 (en) 2002-02-28
JP2006232840A (ja) 2006-09-07
KR100447696B1 (ko) 2004-09-08
KR20010025093A (ko) 2001-03-26
CN1311796A (zh) 2001-09-05
JP2002516342A (ja) 2002-06-04
WO1999061476A1 (en) 1999-12-02
PL344415A1 (en) 2001-11-05
NO326871B1 (no) 2009-03-09
PL200471B1 (pl) 2009-01-30
NZ507912A (en) 2002-10-25
TWI247748B (en) 2006-01-21
BG65065B1 (bg) 2007-01-31
BR9910639A (pt) 2002-01-15
EP1078002B1 (de) 2008-05-21
CZ299639B6 (cs) 2008-10-01
DE69938782D1 (de) 2008-07-03
HUP0102579A2 (hu) 2002-01-28
CZ20004327A3 (cs) 2001-08-15
JP2006001923A (ja) 2006-01-05
HK1037376A1 (en) 2002-02-08
JP3753612B2 (ja) 2006-03-08
CA2329250A1 (en) 1999-12-02
CO5080726A1 (es) 2001-09-25
NO20005890L (no) 2001-01-12
AU4407599A (en) 1999-12-13
TR200003442T2 (tr) 2001-03-21
CA2329250C (en) 2012-03-27
CY1109118T1 (el) 2014-07-02
NO20005890D0 (no) 2000-11-21
BG105064A (en) 2001-08-31
ES2307337T3 (es) 2008-11-16
SI1078002T1 (sl) 2008-10-31
SK17632000A3 (sk) 2001-07-10
PT1078002E (pt) 2008-09-02
JP3795906B2 (ja) 2006-07-12
EP1078002A1 (de) 2001-02-28
AU764277B2 (en) 2003-08-14
SK286554B6 (sk) 2008-12-05
AR018371A1 (es) 2001-11-14

Similar Documents

Publication Publication Date Title
ATE396204T1 (de) Peptide als antiangiogene arzneimittel
NO982097D0 (no) Peptider
NO982098D0 (no) Peptider
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK1042359T3 (da) k-Opioidreceptorpeptider
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
ATE317854T1 (de) Hepatitis c inhibitor peptide
IS4664A (is) Ný peptíð-ópíóíð
DE69911579D1 (de) Antimikrobielle peptide
NO985680L (no) Peptidderivater
ATE196152T1 (de) Peptidderivate
EE04001B1 (et) Peptiidne farmatseutiline kompositsioon
NO994619D0 (no) Farmasöytiske blandinger
DE69926012D1 (de) Arzneizubereitungen
NO20003141D0 (no) Farmasøytiske blandinger
DE69903553D1 (de) Verkapselung wasserlöslicher peptide
NO20004167L (no) Kaspase-8 interagerende proteiner
DE69906934D1 (de) Arzneizubereitungen
DE69720266D1 (de) Vielfältig verzweigte peptidkonstruktionen
NO981052D0 (no) Peptidderivater
FI973371A0 (fi) Nya isolerade peptider
NO20013933D0 (no) Peptider
NO20012283D0 (no) Koblede peptider
DE69633457D1 (de) Antineoplastische peptide
NO992079D0 (no) Isinhiberende peptider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1078002

Country of ref document: EP